ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CTKB Cytek Biosciences Inc

5.76
0.13 (2.31%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cytek Biosciences Inc CTKB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.13 2.31% 5.76 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.69 5.59 5.76 5.76 5.63
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/3/202407:00GLOBECytek® Biosciences Names William McCombe Chief Financial..
08/3/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:30GLOBECytek® Biosciences Opens New Facility to Address Increasing..
01/3/202405:06EDGAR2Form 8-K - Current report
28/2/202416:05GLOBECytek Biosciences Reports Fourth Quarter and Full Year 2023..
27/2/202405:06EDGAR2Form 8-K - Current report
22/2/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:10GLOBECytek Biosciences to Participate in Upcoming Investor..
07/2/202415:05GLOBECytek Biosciences to Report Fourth Quarter and Full Year..
17/1/202416:30GLOBECytek® Biosciences Signs Agreement with CRG and UPF to..
09/1/202405:05EDGAR2Form 8-K - Current report
08/1/202408:00GLOBECytek Biosciences Announces Preliminary Full Year 2023..
28/12/202315:05GLOBECytek Biosciences to present at the 42nd Annual J.P. Morgan..
27/12/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:00GLOBECytek® Biosciences Introduces the Cytek Orion™ Reagent..
19/12/202315:28EDGAR2Form 144 - Report of proposed sale of securities
28/11/202306:00EDGAR2Form 8-K - Current report
27/11/202319:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:17EDGAR2Form 144 - Report of proposed sale of securities
14/11/202315:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202315:05GLOBECytek Biosciences to participate in the Piper Sandler 35th..
13/11/202315:02EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202305:06EDGAR2Form 8-K - Current report
08/11/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202308:00GLOBECytek® Aurora™ CS System Wins BioTech Breakthrough Award for..
07/11/202315:45EDGAR2Form 8-K - Current report
07/11/202315:05GLOBECytek Biosciences Reports Third Quarter 2023 Financial..
25/10/202317:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202315:03EDGAR2Form 144 - Report of proposed sale of securities
23/10/202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202315:05GLOBECytek Biosciences to Report Third Quarter 2023 Financial..
19/10/202315:02EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

Delayed Upgrade Clock